HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative
Journal
JHEP reports : innovation in hepatology
Journal Volume
6
Journal Issue
1
Pages
100956
Date Issued
2024-01
Author(s)
Hosaka, Tetsuya
Suzuki, Fumitaka
Chiang, Chieh
Kumada, Hiromitsu
Yang, Wan-Ting
Abstract
Risk scores have been designed to predict the development of hepatocellular carcinoma (HCC) in treatment-naive patients with chronic hepatitis B (CHB). However, little is known about their predictive accuracy in HBeAg-negative patients in the grey zone (GZ). We aimed to develop a HBcrAg-based HCC risk score and explore whether it outperforms other risk scores in GZ patients.
Subjects
ERADICATE-B; Grey zone; HBcrAg; HCC; Hepatocellular carcinoma
SDGs
Type
journal article